Gilmore O'Neill, incoming Editas Medicine CEO

With Ed­i­tas' third CEO in as many years, ex­pect a new CMO and new de­vel­op­ment part­ners

Sarep­ta Ther­a­peu­tics CMO Gilmore O’Neill will take over as CEO and pres­i­dent of CRISPR biotech Ed­i­tas Med­i­cine on June 1.

But al­ready in the hours …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.